International Finance
Featured Healthcare

Egyptian healthtech DilenyTech raises $160,000 non-equity grant

The startup will use the funds to expand its AI-enabled platform

Egypt-based healthtech startup DilenyTech has secured around $160,000 non-equity grant, media reports said. The funds will be provided by the Information Technology Academia Collaboration (ITAC) programme affiliated with the Information Technology Industry Development Agency (ITIDA).

DilenyTech will use the funds to expand its AI-enabled platform that detects breast cancer. The startup develops solutions for medical imaging analysis, breast cancer risk assessment, and structured reporting in several medical applications. Founded in 2018, DilenyTech has been one of the fastest growing healthtech startups in Africa. The startup recently launched its platform in Arabic and in English.

Last month, it was reported that Egyptian telemedicine startup Docspert Health secured an undisclosed amount of seed funding. It will use the funds to help it expand its services across all of Egypt, and then into the Arabian Gulf.

In this regard, Hisham Mehanna, chairman of Docspert Health and a head and neck cancer surgeon told the media, “We are extremely pleased to have closed this deal with a group of angel investors from Silicon Valley and London.”

“The investors were particularly attracted not only to our innovative platform and business model, but also to our ethos of social responsibility. They were keen to help Docspert Health in its journey to provide the best medical advice to the people of the Middle East and Africa.”

During the same period, another Egyptian healthtech VRapeutic has joined the Canadian MakerLaunch accelerator programme at the University of Ottawa. By joining the programme, the startup plans to expand in the Canadian market.

Leave a Comment

* By using this form you agree with the storage and handling of your data by this website.